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Fibrosis is a complication of chronic inflammatory disorders such as 
Introduction
55
Intestinal fibrosis is a debilitating complication of inflammatory bowel disease 56 (IBD) (16, 19, 58) . Most approaches to therapeutic intervention in IBD are 57 focused on the control of inflammation rather than fibrosis(58). However, 58 surgical intervention is commonly necessary due to the formation of fibrotic 59 tissue (58, 63) . Therefore, there is an unmet clinical need for therapies that 60 suppress pro-fibrotic pathways in IBD.
61
Fibrosis occurs as a result of an overactive wound healing response and is 62 characterized by excessive deposition of extracellular matrix (ECM) (16, 47, 63 58). Fibrosis is a complication of multiple chronic inflammatory disorders 64 including chronic kidney disease (12, 55) , interstitial lung disease(1, 79) and 65 chronic liver disease(38, 50) as well as IBD (16, 19, 81) . At a cellular level, 66 fibrosis occurs as the result of the over-activation of fibroblasts and other ECM-67 producing cells (1, 12, 16, 79) . Among the factors regulating fibrosis, 68 transforming growth factor-β1 (TGF-β1) is the key regulator of healing 69 responses that is implicated in most fibrotic disorders (10, 16, 19, 38) . The termed factor inhibiting HIF (FIH) , that controls HIF transcriptional activity.
82
The PHD2 isoform is the main regulator of HIF stability through targeting HIF-83 alpha subunits for hydroxylation-dependent proteosomal degradation(7). These 84 enzymes have also been identified as key players in inflammatory responses (13, 85 20, 53, 61) . Hydroxylase inhibitors have recently been found to be well 86 tolerated in patients in clinical trials for efficacy in anemia(9, 28). These 87 compounds have also been found to ameliorate inflammation in multiple animal 88 models of colitis (14, 15, 22, 36, 60, 64 
Estimation of disease parameters and histologic analysis
150
Body weight, presence of blood in feces, and stool consistency/diarrhea were 151 recorded daily for each mouse to determine the disease activity index (DAI).
152
These parameters were scored as previously described(64). On termination of inflammation, sections were stained using hematoxylin and eosin (H&E).
158
Images were taken using an Aperio scanscope XT (Aperio technologies, Vista, 159 CA, U.S.A). Tissue inflammation was assessed in a blinded fashion by 2-3 160 independent experienced observers and expressed as an average between the 161 estimations provided. The score was calculated as previously described(61). Alternatively, the lamina propria was separated using a drawing tool and total 177 mucosal collagen quantified as the percentage of black over a white 178 background.
179
To analyse the presence of activated fibroblasts in the colon, 180 immunofluorescent staining for α-SMA was performed using 4', 6-diamidino-2- 
luciferase reporter studies
213
All transfections were performed following previously described methods(52). 
293
In order to investigate whether the effects of hydroxylase inhibition on fibrosis 294 were due to its anti-inflammatory actions or to direct anti-fibrotic effects on 295 fibroblasts, we investigated the effects of hydroxylase inhibitors on TGF-β1-296 induced fibroblast activation. As shown in Figure 3A , human colonic CCD- 
327
Treatment with DMOG failed to reduce Smad2 phosphorylation at any time 328 point, although it modestly reduced levels of pSmad3 at 2 hours ( figure 4C-4E ).
329
The combination of hydroxylase and proteosome inhibition did not further 
The antifibrotic effect of hydroxylase inhibitors is independent of HIF
377
Our previous in vivo studies demonstrated no protective effects of PHD2 378 deficiency against fibrosis, thus providing evidence that the antifibrotic effects inflammation-associated fibrosis, using the DSS-induced murine colitis model.
416
We show that treatment with the pan-hydroxylase inhibitor DMOG during the The ability of hydroxylase inhibitors to regulate the stability of HIF-α subunits 500 may have not only beneficial effects, but also potential adverse effects. A 501 widely discussed side effect of hydroxylase inhibitors is the activation of HIF-502 dependent EPO production (6, 30, 33) , which is seen as an important limitation 503 to the use of these drugs. However, this ability to increase EPO is currently 504 being investigated as a therapy for anemia (6, 9, 28) . In IBD, anemia is one of (16, 18, 24, 59, 74) Actin in MEF stimulated with 1ng/ml TGF-β1 and treated with 1mM DMOG (n=6); C, 893 representative western blot of pMEK and β-Actin in MEF stimulated with 1ng/ml TGF-β1 and 894 treated with 1mM DMOG (n=5). D, densitometry for pERK of the western blots described in B 895 (n=6); E, densitometry for pMEK of the western blots described in C (n=5). F, representative 896 western blot of pERK, TotalERK, pMEK, TotalMEK and β-Actin in MEF stimulated with 1ng/ml 897 TGF-β1 and treated with 100μM JNJ1935 or 1% oxygen (n≥3); G, densitometry for pERK of the 898 western blots described in F; H, representative western blot of pSmad2 linker, pERK, pMEK and β-899
Actin in MEF treated with 1mM DMOG or 100μM JNJ1935 or 0.3mM PD184161 and stimulated 900 with 1ng/ml of TGF-β1 (n=4). * p≤0.05; ** p≤0.01. 901 
